Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 149,099 | 95,287 | 81,948 | 51,269 | 224,462 |
| Marketable Securities | 518,141 | 454,378 | 548,780 | 606,922 | 502,933 |
| Receivables | 8,804 | 35,936 | 4,574 | 48,746 | 2,060 |
| Inventories | 413 | N/A | N/A | N/A | N/A |
| TOTAL | $708,663 | $620,663 | $660,075 | $724,198 | $744,829 |
| Non-Current Assets | |||||
| PPE Net | 7,855 | 7,397 | 3,912 | 2,348 | 1,682 |
| Other Non-Current Assets | 21,845 | 21,321 | 18,438 | 17,218 | 13,648 |
| TOTAL | $29,700 | $28,718 | $22,350 | $19,566 | $15,330 |
| Total Assets | $738,363 | $649,381 | $682,425 | $743,764 | $760,159 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 4,337 | 3,112 | 1,921 | 2,607 |
| Accounts payable and accrued liabilities | 5,017 | 66,788 | 52,931 | 45,094 | 1,469 |
| Accrued Expenses | 61,697 | N/A | N/A | N/A | 48,484 |
| Other current liabilities | 48,983 | 48,750 | 49,435 | 40,846 | 24,271 |
| TOTAL | $116,974 | $121,304 | $107,174 | $89,766 | $78,712 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,711 | 5,336 | 6,509 | 7,650 | 6,916 |
| Other Non-Current Liabilities | 437,543 | 280,199 | 263,256 | 281,942 | 260,891 |
| TOTAL | $447,254 | $285,535 | $269,765 | $289,592 | $267,807 |
| Total Liabilities | $564,228 | $406,839 | $376,939 | $379,358 | $346,519 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,330 | 87,018 | 86,797 | 86,575 | 80,755 |
| Common Shares | 9 | 9 | 9 | 8 | 8 |
| Retained earnings | -1,174,088 | -1,093,089 | -1,018,973 | -952,851 | -895,422 |
| Other shareholders' equity | 1,024 | 918 | 711 | 974 | 764 |
| TOTAL | $174,135 | $242,542 | $305,486 | $364,406 | $413,640 |
| Total Liabilities And Equity | $738,363 | $649,381 | $682,425 | $743,764 | $760,159 |